Vaccinare
La vaccinazione contro l’epatite A: novitŕ, considerazioni e raccomandazioni
GIORGIO BARTOLOZZI
Direttore Scientifico, Azienda “Meyer”, Firenze
Settembre 2000 - pagg. 453 -455
Classificazione MeSH
Bibliografia
1. Mele A, et al. Workshop Consensus Conference.
Vaccinazione antiepatite virale A: indicazioni
per la strategia vaccinale. Medico e
Bambino 1996;15:104-6.
2. Ministero della Sanitŕ. Bollettino epidemiologico n. 16, anno 1998, Roma.
3. CDC: Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48 (RR12):1-37.
4. Germinarlo C, Lopalco PL, Chicanna M, Da Villa G. From hepatitis A and B prevention: the Puglia (Italy) experience. Vaccine 2000;18:S 83-5.
5. Rosenblum LS, Villarino ME, Nainan OV, et al. Hepatitis A outbreak in a neonatal intensive care unit: risk factor for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 1991;164:476-82.
6. Sagliocca L, Amoroso P, Stroffolini T, et al. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomized randomized trial. Lancet 1999;353:1136-9.
7. Bonanni P, Colombai R, Franchi G, et al. Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy. Epidemiol Infect 1998;121:377-80.
8. Lemon SM. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine. J Hepatol 1993;18,suppl 2:S15-9.
9. Maggiore G. Chi vaccinare contro l’epatite A nel 1996? Medico e Bambino 1996;15:103-4.
10. Vento S, Garofano T, Ronzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286-90.
11. Bell BP, Shapiro CN, Alter MJ, et al. The diverse patterns of hepatitis A epidemiology in the United States; implications for vaccination strategies. J Infect Dis 1998;178:1579-84.
2. Ministero della Sanitŕ. Bollettino epidemiologico n. 16, anno 1998, Roma.
3. CDC: Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48 (RR12):1-37.
4. Germinarlo C, Lopalco PL, Chicanna M, Da Villa G. From hepatitis A and B prevention: the Puglia (Italy) experience. Vaccine 2000;18:S 83-5.
5. Rosenblum LS, Villarino ME, Nainan OV, et al. Hepatitis A outbreak in a neonatal intensive care unit: risk factor for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis 1991;164:476-82.
6. Sagliocca L, Amoroso P, Stroffolini T, et al. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomized randomized trial. Lancet 1999;353:1136-9.
7. Bonanni P, Colombai R, Franchi G, et al. Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy. Epidemiol Infect 1998;121:377-80.
8. Lemon SM. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine. J Hepatol 1993;18,suppl 2:S15-9.
9. Maggiore G. Chi vaccinare contro l’epatite A nel 1996? Medico e Bambino 1996;15:103-4.
10. Vento S, Garofano T, Ronzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286-90.
11. Bell BP, Shapiro CN, Alter MJ, et al. The diverse patterns of hepatitis A epidemiology in the United States; implications for vaccination strategies. J Infect Dis 1998;178:1579-84.